Comparing Cosopt vs Lumigan
| Cosopt (dorzolamide / timolol) | Lumigan (bimatoprost) |
|
|---|
| Cosopt (dorzolamide / timolol) | Lumigan (bimatoprost) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Glaucoma - Open Angle, Intraocular Hypertension. Cosopt may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Intraocular Hypertension, Glaucoma - Open Angle. Lumigan may also be used for purposes not listed in this medication guide. |
Related suggestions Glaucoma, Open Angle
Intraocular Hypertension
|
|||||||
| More about Cosopt (dorzolamide / timolol) | More about Lumigan (bimatoprost) | ||||||||
| Ratings & Reviews | |||||||||
|
Cosopt has an average rating of 4.4 out of 10 from a total of 8 ratings on Drugs.com. 13% of reviewers reported a positive effect, while 50% reported a negative effect. |
Lumigan has an average rating of 5.2 out of 10 from a total of 25 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Cosopt side effects |
View all Lumigan side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Cosopt prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Other dorzolamide / timolol brands include: Cosopt PF | Other bimatoprost brands include: Durysta | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
0.75 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 291 drugs are known to interact with Cosopt:
|
A total of 7 drugs are known to interact with Lumigan:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
April 07, 1998 |
March 16, 2001 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
|||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.